Overview
Crohn disease affecting the upper gastrointestinal (GI) tract involves inflammation primarily in the esophagus, stomach, and duodenum, distinct from more common lower GI manifestations. 35Diagnosis
Esophagogastroduodenoscopy (EGD): Essential for visualizing mucosal changes, obtaining biopsies, and diagnosing inflammatory conditions 35.
Double-contrast upper GI radiograph: Useful for detailed evaluation of subtle inflammatory and neoplastic lesions in the esophagus, stomach, and duodenum 7.
Endoscopic biopsy: Critical for histopathological confirmation and grading of disease severity 35.Management
Endoscopic Therapy: Increasingly used to manage complications such as strictures and bleeding, potentially avoiding surgical intervention 5.
Medical Management: Includes anti-inflammatory drugs (e.g., aminosalicylates, corticosteroids) tailored to disease severity 5.
Proton Pump Inhibitors (PPIs): Often used for managing acid-related symptoms and complications 1.
Biologics: Considered for refractory cases, though specific dosing details are not provided in the abstracts 5.Special Populations
Elderly: Require careful monitoring due to increased comorbidities and potential drug interactions; EGD remains crucial for diagnosis and management 6.
Pediatrics: Not specifically addressed in the provided abstracts.
Pregnancy: Management considerations not detailed in the abstracts; individualized care with close monitoring is advised 5.Key Recommendations
Utilize esophagogastroduodenoscopy for both diagnostic evaluation and therapeutic interventions in upper GI Crohn disease (Evidence: Strong 35).
Employ double-contrast imaging for detailed anatomical assessment when endoscopic findings are inconclusive (Evidence: Moderate 7).
Integrate endoscopic techniques with medical management, including PPIs and anti-inflammatory agents, tailored to disease activity (Evidence: Moderate 15).References
1 Yeomans ND. Overview of 50 years' progress in upper gastrointestinal diseases. Journal of gastroenterology and hepatology 2009. link
2 Rassadi R, Dickerman RM, Dunn EL, Tarnasky PR, Linder JD, Mejia A et al.. Hepatopancreaticobiliary (HPB) surgery: what is the right fellowship for the right training?. Journal of surgical education 2008. link
3 O'Connor JJ. Office esophagogastroduodenoscopy. International surgery 2007. link
4 Mendes LC, Peiró JR, Feitosa FL, Luvizotto MC, Borges AS, Ciarlini PC et al.. Effect of age and abomasal puncture on peritoneal fluid, hematology, and serum biochemical analyses in young calves. Journal of veterinary internal medicine 2005. link
5 Cappell MS, Friedel D. The role of esophagogastroduodenoscopy in the diagnosis and management of upper gastrointestinal disorders. The Medical clinics of North America 2002. link00075-5)
6 Eyre-Brook IA, Lalla R. Gastrointestinal surgical workload in the DGH and the upper gastrointestinal surgeon. Annals of the Royal College of Surgeons of England 1999. link
7 Trenkner SW, Laufer I. Double-contrast examination. Part I: Oesophagus, stomach and duodenum. Clinics in gastroenterology 1984. link